Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18173
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStevens, Hannah-
dc.contributor.authorRaj, Kavita-
dc.contributor.authorAshby, Michael-
dc.contributor.authorGrigg, Andrew P-
dc.date2017-10-31-
dc.date.accessioned2018-08-08T02:11:11Z-
dc.date.available2018-08-08T02:11:11Z-
dc.date.issued2018-07-
dc.identifier.citationLeukemia & lymphoma 2018; 59(7): 1750-1752-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18173-
dc.language.isoeng-
dc.titleAllogeneic stem cell transplantation as a risk factor for recurrent melanoma.-
dc.typeJournal Article-
dc.identifier.journaltitleLeukemia & lymphoma-
dc.identifier.affiliationDepartment of Clinical Haematology, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationDepartment of Haematology, King's College Hospital, London, UK-
dc.identifier.doi10.1080/10428194.2017.1393670-
dc.identifier.pubmedid29087220-
dc.type.austinJournal Article-
local.name.researcherGrigg, Andrew P
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

20
checked on Dec 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.